EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of metagenomic next-generation sequencing in the diagnosis of post-stroke infections: a case series study using multiple sample types

Xiaopu Chen, Yong Liang, Wei Yang, Wenzhen He, Zhiqiang Xing, Shunxian Li, Shaoyu Cai, Jiping Fu, Xiaotang Peng, Manli Chen, Jiaming Wu

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2024.1386377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Xiaopu Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metagenomic high-throughput sequencing (mNGS) represents a powerful tool for detecting nucleic acids from various pathogens, such as bacteria, fungi, viruses and parasites, in clinical samples. Despite its extensively employed in the pathogen diagnosis for various infectious diseases, its application in diagnosing stroke-related infection, and its potential impact on clinical decision-making, anti-infection treatment, clinical intervention, and patient prognosis remain insufficiently explored. Additionally, while mNGS offers promising potential, it facts limitations related to sensitivity, specificity, cost, and standardization, which could influence its integration into routine clinical practice.

Methods

We retrospectively analyzed 18 stroke patients admitted to the First Affiliated Hospital of Medical College of Shantou University from January to February 2023, comparing culture-based methods with mNGS detection, and assessing its significance in etiological diagnosis. Additionally, we evaluated the performance differences among various sequencing platforms.

Results

Among the 18 stroke patients enrolled, pulmonary infections were identified in 7 cases, urinary tract infections in 1 case, central nervous system infections in 10 cases, and combined pulmonary and central nervous system infections in 2 cases, with 2 cases yielding negative results. mNGS detected pathogens in 13 cases, aligning with clinical diagnoses (75% concordance), whereas culture-based methods yielded positive results in only 6 cases (22% concordance). Importantly, for 9 of the 18 patients, adjustments to anti-infective treatment regimens based on mNGS results led to improved symptomatic relief and infection control. This suggests that mNGS can contribute to more timely and precise treatment modifications, particularly for infections with low pathogen loads, potentially enhancing clinical outcomes.

Conclusion

Our findings highlights the utility of mNGS in diagnosing stroke-associated infections by providing a more comprehensive etiological diagnosis compared to traditional method. While mNGS shows promise in enhancing diagnostic accuracy and guiding clinical treatment, it high cost and technical challenges need addressing before widespread clinical adoption. Future research should focus on optimizing mNGS protocols, integration it with convertional diagnostic tools, and evaluating its cost-effectiveness and clinical impact through larger, multicentric studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingMetagenomicsStrokeHumansRetrospective StudiesMaleFemaleAgedMiddle AgedAged, 80 and overSensitivity and SpecificityCentral Nervous System InfectionsBacteriaAdultUrinary Tract Infections

Stichwörter der Autor:innen

department of neurologydiagnostic effectnext-generation sequencingstroke-related infectionstreatment

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
  • Department of Research and Development, Shenzhen Xbiome Biotech Co. Ltd., Shenzhen, China.
  • GeneMind Biosciences Company Limited, Shenzhen, Guangdong, China.
  • Department of Diagnosis Technology Transformation, SK Medical Technology Co, Ltd, Beijing, China.

Zitieren

APA

Chen, X., Liang, Y., Yang, W., He, W., Xing, Z., Li, S., Cai, S., Fu, J., Peng, X., Chen, M., & Wu, J. (2025). Application of metagenomic next-generation sequencing in the diagnosis of post-stroke infections: a case series study using multiple sample types. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1386377

Vancouver

Chen X, Liang Y, Yang W, He W, Xing Z, Li S, et al. Application of metagenomic next-generation sequencing in the diagnosis of post-stroke infections: a case series study using multiple sample types. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2024.1386377

BibTeX
@article{Chen2025,
  author = {Chen, Xiaopu and Liang, Yong and Yang, Wei and He, Wenzhen and Xing, Zhiqiang and Li, Shunxian and Cai, Shaoyu and Fu, Jiping and Peng, Xiaotang and Chen, Manli and Wu, Jiaming},
  title = {Application of metagenomic next-generation sequencing in the diagnosis of post-stroke infections: a case series study using multiple sample types},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2024.1386377}
}
Kostenlos starten →